Satellos Bioscience

MSCL.TO

Biotechnology · Healthcare

Price

C$13.51

-0.30 (-2.17%)

Market Cap

C$281.4M

Exchange

Toronto Stock Exchange

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

Track this stock — start free trial

Share count rising — dilution

+627.5% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 2.0M (2021) → 14.6M (2025)

Winston Score History

The full picture

Satellos Bioscience is a Canadian biotechnology company focused on developing drugs to treat muscle diseases. Its main area of research targets Duchenne muscular dystrophy, a rare and serious genetic condition that causes muscles to weaken over time, mostly affecting young boys. The company is in early-stage drug development and does not yet sell any approved products.

Satellos earns no product revenue today. It funds its research through equity financing, meaning it raises money by selling shares to investors. The company is based in Vancouver, Canada, and operates at a loss, which is typical for early-stage biotech firms. Its competitive position depends entirely on whether its lead drug candidate, SAT-3247, can succeed in clinical trials and eventually win regulatory approval — if trials fail or funding runs out, the company faces significant risk of being unable to continue operations.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

Revenue data limited

EPS Growth

-41.0% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$19M/ year

→ Flat (-4% vs prior year)

Steady R&D investment year-over-year

Insider Activity

29.1%ownership

↑ Rising

Insiders increasing their stake — aligned with shareholders

Cash Runway

~2 years

$62M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Adequate runway but may need to raise capital within 2 years

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

N/A

—

Data not available

Profit after running costs

Operating Margin

N/A

—

Data not available

Return on the money invested

ROCE

-59.6%

Weak — -59.6% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

N/A

—

Data not available

Profit growth

EPS YoY

N/A

—

Data not available

How steady the profit is

EPS Consistency

4/8 quarters

Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

—

Data not available

Spare cash per sale

FCF Margin

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

N/A

Data not available

Covers its interest

Interest Cover

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

—

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial